Chartwell Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL, and what generic and branded alternatives to CHARTWELL drugs are available?
CHARTWELL has five hundred and twenty-seven approved drugs.
There are three tentative approvals on CHARTWELL drugs.
Drugs and US Patents for Chartwell
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | PIRFENIDONE | pirfenidone | TABLET;ORAL | 212403-002 | Aug 23, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Rx | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 077515-004 | Jun 13, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Rx | CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 072277-001 | May 9, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chartwell
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-007 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Try a Trial |
Chartwell Rx | LIMBITROL DS | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 016949-002 | Approved Prior to Jan 1, 1982 | 4,316,897 | ⤷ Try a Trial |
Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-004 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.